A new peer-reviewed study conducted in Japanese universities has found a way to diagnose early-stage brain cancer or brain tumors with a urine sample. The nano-technological device, created by Yasui and Professor Yoshinobu Baba of Nagoya University’s Graduate School of Engineering, Nagoya University’s Institute of Innovation for Future Society, and the University of Tokyo, can be used to identify proteins in EVs, CD31, and CD63 (which are in brain tumors and the urine of people with them).
How Does It Work?
There is a specific type of EV in the urine of patients with brain tumors. These EVs have proteins and RNAs that indicate cancer. The purpose of the invention of the device is to determine them.
Importance of the Study
Survival rates for brain cancer have not increased over the past 20 years. Among other things, this problem is associated with the late detection of this diagnosis. And the reason for the examination is a speech or coordination disorder. Such symptoms often occur when the tumor is already too large. The test reduces the need for invasive ones, so the risk of late detection decreases since it will be possible to identify the tumor or cancer early enough for surgery. According to the National Cancer Institute, poverty is one of the factors that reduces the likelihood of recovery. The average cost of a CT brain scan in the United States ranges from $825-4000, and an MRI brain scan from $1600-8400 on average. With this new urine-based test, an early cancer diagnosis will become more affordable and attainable for many patients.
Source: https://m.jpost.com/health-and-wellness/article-730561
Discover more from Doctor Trusted
Subscribe to get the latest posts sent to your email.
